Immunotherapeutic Potential of Mollusk Hemocyanins in Murine Model of Melanoma
Marine Drugs · 2024
DOI: 10.3390/md22050220 ↗Kurz gefasst
Fachartikel in der Zeitschrift Marine Drugs, 2024. Verfasst von Emiliya Stoyanova und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, Stefan Angeloff Institute of Microbiology, Bulgarian Academy of Sciences, Acad. G. Bonchev Street, Block 26, 1113 Sofia, Bu…. Hauptthemen laut MEDLINE: Mice, Inbred C57BL, Melanoma, Experimental, Hemocyanins. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Bulgarian Science Fund, National science program Young scientists and postdoctoral researchers, National Science Fund, Bulgaria.
Abstract (Originalsprache)
The development of antitumor drugs and therapy requires new approaches and molecules, and products of natural origin provide intriguing alternatives for antitumor research. Gastropodan hemocyanins-multimeric copper-containing glycoproteins have been used in therapeutic vaccines and antitumor agents in many cancer models. Materials and Methods: We established a murine model of melanoma by challenging C57BL/6 mice with a B16F10 cell line for solid tumor formation in experimental animals. The anticancer properties of hemocyanins isolated from the marine snail Rapana thomasiana (RtH) and the terrestrial snail Helix aspersa (HaH) were evaluated in this melanoma model using various schemes of therapy. Flow cytometry, ELISA, proliferation, and cytotoxicity assays, as well as histology investigations, were also performed.
Results
Beneficial effects on tumor growth, tumor incidence, and survival of tumor-bearing C57BL/6 mice after administration of the RtH or HaH were observed. The generation of high titers of melanoma-specific IgM antibodies, pro-inflammatory cytokines, and tumor-specific CTLs, and high levels of tumor-infiltrated M1 macrophages enhanced the immune reaction and tumor suppression.
Discussion
Both RtH and HaH exhibited promising properties for applications as antitumor therapeutic agents and future experiments with humans.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Immunology, Stefan Angeloff Institute of Microbiology, Bulgarian Academy of Sciences, Acad. G. Bonchev Street, Block 26, 1113 Sofia, Bulgaria.
- Institute of Organic Chemistry with Centre of Phytochemistry, Bulgarian Academy of Sciences, 1113 Sofia, Bulgaria.
ORCID-Profile: Nikolina Mihaylova, Iliyan Manoylov
Förderung
- Bulgarian Science Fund
- National science program Young scientists and postdoctoral researchers
- National Science Fund, Bulgaria
Zitieren
APA
Stoyanova, E., Mihaylova, N., Ralchev, N., Bradyanova, S., Manoylov, I., Raynova, Y., Idakieva, K., & Tchorbanov, A. (2024). Immunotherapeutic Potential of Mollusk Hemocyanins in Murine Model of Melanoma. Marine Drugs. https://doi.org/10.3390/md22050220
Vancouver
Stoyanova E, Mihaylova N, Ralchev N, Bradyanova S, Manoylov I, Raynova Y, et al. Immunotherapeutic Potential of Mollusk Hemocyanins in Murine Model of Melanoma. Marine Drugs. 2024. doi:10.3390/md22050220
BibTeX
@article{Stoyanova2024,
author = {Stoyanova, Emiliya and Mihaylova, Nikolina and Ralchev, Nikola and Bradyanova, Silviya and Manoylov, Iliyan and Raynova, Yuliana and Idakieva, Krassimira and Tchorbanov, Andrey},
title = {Immunotherapeutic Potential of Mollusk Hemocyanins in Murine Model of Melanoma},
journal = {Marine Drugs},
year = {2024},
doi = {10.3390/md22050220}
}
EUVIMED